Evidence map›Paper›PMID 36040667›Full record

ArticleJournal of cancer research and clinical oncology2023

Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.

Leila Eini, Marzieh Naseri, Feridoun Karimi-Busheri, Mahmood Bozorgmehr, Roya Ghods, Zahra Madjd

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Harnessing cancer stem cell-derived exosomes to improve cancer therapy.Journal of experimental & clinical cancer research : CR · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leila EiniOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Marzieh NaseriOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Feridoun Karimi-BusheriDepartment of Oncology, University of Alberta, Edmonton, Canada.
Mahmood BozorgmehrOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Roya GhodsOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. ghods.ro@iums.ac.ir.ORCID http://orcid.org/0000-0001-5996-3758
Zahra MadjdOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. majdjabari.z@iums.ac.ir.ORCID http://orcid.org/0000-0001-7329-2583

Funding

Iran University of Medical Sciences 96-01-126-30817
6 · The paper itself

Abstract

backgroundCancer stem cells (CSCs), a rare sub-fraction of tumor cells, with the capability of self-renewal and strong oncogenicity are tightly responsible for chemo and radio resistance and tumor metastasis in colorectal cancer. Hence, CSCs targeting would improve the efficacy of therapeutic strategies and clinical outcomes.

methodsHere, using three-dimensional CSC spheroids and syngeneic mice model, we evaluated the cancer preventive impact of CSCs-based vaccination. CSCs enrichment was performed via colonosphere formation from CT-26 cell line and CT-26-derived tumor biopsy and characterized by confirming high expression of key stemness genes (OCT4, SOX2, and NANOG) and CSC-related surface biomarkers (CD166, DCLK1, and CD133) via real-time PCR and flow cytometry, respectively. Then, the stemness phenotype and self-renewal in CSC-enriched spheroids were further confirmed by showing serial sphere formation capacity, clonogenicity potential, and enhanced in vivo tumorigenic capacity compared to their parental counterparts. CSCs lysates were used as vaccines in prophylactic settings compared to the parental cell lysate and PBS groups.

resultImmunization of syngeneic mice with CSCs lysates was effective in the prevention of tumor establishment and significantly decreased tumor growth rate accompanied by an improvement in survival rate in tumor-bearing mice compared to groups subjected to parental cells lysate and PBS. These results, for the first time, showed that mice immunized with cell lysate from tumor biopsy-derived spheroids are resistant to tumor induction. Immunofluorescence staining indicated that only the serum antibodies from CSC-vaccinated mice reacted with colonospheres.

conclusionsThese findings represent CSCs lysate-based vaccination as a potential approach to hampering immunotherapy failure of colorectal cancer which along with other traditional therapies may effectively apply to prevent the establishment of aggressive tumors harboring stemness features.

Indexed as

AdenocarcinomaColonic NeoplasmsAnimalsCell Line, TumorCell ProliferationDisease Models, AnimalMiceNeoplastic Stem CellsVaccinationCancer stem cells (CSCs)Colorectal cancer (CRC)ImmunotherapyPreventive CSCs-based vaccinationSpheroid formation

Identifiers

PMID36040667
PMCPMC11797665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.